$0.58
6.31% today
Nasdaq, Apr 04, 08:48 pm CET
ISIN
US88688T1007
Symbol
TLRY
Sector
Industry

Tilray, Inc. Series 2 Stock price

$0.62
-0.07 9.58% 1M
-1.08 63.65% 6M
-0.71 53.54% YTD
-2.23 78.32% 1Y
-6.83 91.71% 3Y
-4.92 88.85% 5Y
-21.77 97.24% 10Y
Nasdaq, Closing price Thu, Apr 03 2025
-0.03 5.14%
ISIN
US88688T1007
Symbol
TLRY
Sector
Industry

Key metrics

Market capitalization $579.38m
Enterprise Value $681.60m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 0.82
P/S ratio (TTM) P/S ratio 0.70
P/B ratio (TTM) P/B ratio 0.16
Revenue growth (TTM) Revenue growth 18.38%
Revenue (TTM) Revenue $829.22m
EBIT (operating result TTM) EBIT $-117.74m
Free Cash Flow (TTM) Free Cash Flow $-92.07m
Cash position $252.25m
EPS (TTM) EPS $-0.31
P/E forward negative
P/S forward 0.65
EV/Sales forward 0.76
Short interest 17.92%
Show more

Is Tilray, Inc. Series 2 a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,794 stocks worldwide.

Tilray, Inc. Series 2 Stock Analysis

Unlock Scores for Free

Analyst Opinions

14 Analysts have issued a Tilray, Inc. Series 2 forecast:

4x Buy
29%
10x Hold
71%

Analyst Opinions

14 Analysts have issued a Tilray, Inc. Series 2 forecast:

Buy
29%
Hold
71%

Financial data from Tilray, Inc. Series 2

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Nov '24
+/-
%
829 829
18% 18%
100%
- Direct Costs 662 662
3% 3%
80%
167 167
190% 190%
20%
- Selling and Administrative Expenses 154 154
42% 42%
19%
- Research and Development Expense 0.67 0.67
37% 37%
0%
13 13
125% 125%
2%
- Depreciation and Amortization 130 130
4% 4%
16%
EBIT (Operating Income) EBIT -118 -118
33% 33%
-14%
Net Profit -249 -249
83% 83%
-30%

In millions USD.

Don't miss a Thing! We will send you all news about Tilray, Inc. Series 2 directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Tilray, Inc. Series 2 Stock News

Positive
MarijuanaStocks
about 6 hours ago
Marijuana stock investors are torn between several paths. With how volatile the space is, much of the sector is trading at low price points. It is almost safe to say that more than half of those who have shares in a cannabis company are down. But that doesn't mean that it will stay that way forever. The overall cannabis industry continues to flourish even though that same success doesn't impact...
Negative
Invezz
about 16 hours ago
Cannabis stocks have plunged this year, continuing a trend that has been going on in the past few years as the bubble bursts. Most of them have lost over 50% of their value this year, and are down by over 80% from their all-time highs.
Positive
The Motley Fool
2 days ago
Many valuation metrics suggest that Tilray Brands (TLRY -0.70%) is a screaming buy right now. Just look at the cannabis stock's price-to-sales ratio.
More Tilray, Inc. Series 2 News

Company Profile

Tilray, Inc. engages in the research, cultivation, production, and distribution of medical cannabis and cannabinoids. The Company is focused on medical cannabis research, cultivation, processing and distribution of cannabis products worldwide. Its products include dried cannabis and cannabis extracts. It operates through the following segments: Cannabis and Hemp. The Cannabis segment sales consists of adult-use, medical and bulk sales of cannabis under regulated licenses and sold to retail, wholesale, pharmacy, government, and direct to patient. The Hemp segment sales consist of hemp seed, hemp foods, board spectrum hemp extract containing CBD which are sold in an unlicensed operation and sold to retail, wholesale and direct to consumers. The company was founded on January 24, 2018 and is headquartered in Nanaimo, Canada.

Head office United States
CEO Irwin Simon
Employees 2,650
Founded 2018
Website www.tilray.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today